Cell & Gene Therapy Webinar – Integrated mRNA & circRNA-tLNP Platform Empowering In Vivo CAR-T Therapies 04-16-2026 / Lauren Lu, Sr. Director, Plasmid Business Dept., ProBio RNA therapeutics and targeted lipid nanoparticles (tLNP) are opening new possibilities for engineering CAR-T cells directly in the body. Learn More
Cell & Gene Therapy Webinar-Hopewell Site Capabilities 03-10-2026 / Lance Marquardt, Director of Manufacturing Operations Hopewell,New Jersey In June 2025, ProBio CDMO, the biologics subsidiary of GenScript, expanded its plasmid DNA and viral vector production capacity with the opening of its flagship Cell and Gene Therapy Center of Excellence, at the Princeton West Innovation Campus in Hopewel Learn More
Cell & Gene Therapy In Vivo CAR T Made Real: Overcoming CMC Barriers 01-21-2026 / Jie Ma, Associate Director, Head of Product Marketing, ProBio Cell and gene therapies (CGT) are transforming disease treatment, with CAR-T therapies facing challenges like high costs and long production times. Learn More
Cell & Gene Therapy In Vivo CAR-T Webinar | Industrialization of In Vivo CAR-T Therapy Development | ProBio CDMO 12-02-2025 / Chunling Xuan, Director, LVV PD, ProBio;Jiang Xu Head of LNP formulation, ProBio; CAR-T therapies have revolutionized blood cancer treatment, but traditional ex vivo manufacturing remains costly and time-consuming. Next-generation in vivo CAR-T is set to change the game, driven by two delivery platforms: LVV (viral) and LNP...... Learn More
Cell & Gene Therapy AAV Webinar | Design, Build & Scale AAV Discovery to Process Development | ProBio CDMO 08-26-2025 / Cheng Luo, Director of Pharmacology Dept., ProBio Adeno-associated viruses (AAVs) are widely used in gene therapy for its safety and ability to support long-term gene expression. Learn More
Cell & Gene Therapy LVV Webinar | From DNA to Therapy: Plasmid & LVV Insights | ProBio CDMO 04-22-2025 / Luffy Chen, Head of Plasmid PD and Production Dept., ProBio Join us on April 22ⁿᵈ for an exclusive webinar on Cell and Gene Therapy (CGT) development! Gain expert knowledge on optimizing plasmid and LVV production timelines, ensuring regulatory compliance, and navigating IND and BLA applications... Learn More
Cell & Gene Therapy Strategies and Solutions for mRNA Therapeutics and Personalized Medicines | ProBio CDMO 05-23-2024 / Dr. Xiao Pan, Director of Platform R&D Dept. Learn More
Cell & Gene Therapy Unlocking Affordability: Cell Therapy Development Strategies to Expand Patient Access | ProBio CDMO 03-28-2024 / Dr. Li Chen, Sr. Director, Biologics Discovery Dept. ProBio VHH is a novel modality in antibody based therapy. Its naturally generated single-domain structure makes it an ideal building block in cell therapy. Learn More